People with diabetes who have fewer routine care processes have higher mortality (Diabetes, Obesity and Metabolism)
Diabetes News
Category: Audits
Young People with Type 2 Diabetes, 2019-20
The National Diabetes Audit (NDA) and the National Paediatric Diabetes Audit (NPDA) provide a comprehensive view of diabetes care in England and Wales (NHS Digital)
National Diabetes Audit, 2019-20 , Type 1 Diabetes
This is the first NDA report dedicated to people with type 1 diabetes (NHS Digital)
Type 1 diabetes in adults: diagnosis and management (update)
You can now review and comment on this draft guideline. The consultation closes on 19 May 2021 at 5pm (NICE)
Type 1 diabetes in adults: diagnosis and management (update)
In development [GID-NG10159] Expected publication date: 21 July 2021. A list of downloadable documents created during development (NICE)
The All‐Wales Medicines Strategy Group: 18 years’ experience of a National Medicines Optimisation Committee
Since 2002, AWMSG has acted as a national medicines optimisation committee in Wales. From the outset, pharmacists and clinical pharmacologists have collaborated closely and shared their complementary expertise to make a much greater contribution to the safe, effective, and cost‐effective use of medicines than either group could have achieved by working separately (British Journal of Clinical Pharmacology)
National Diabetes Audit, Diabetes Prevention Programme (DPP), Quarterly Data Release, 1st January – 30th September 2020
The NHS Diabetes Prevention Programme (DPP) is a joint commitment from NHS England, Public Health England (PHE) and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia
National Diabetes Audit, Non-Diabetic Hyperglycaemia, 2019- 2020, Diabetes Prevention Programme, Data Release
This short report uses data collected from GP practices alongside the National Diabetes Audit (NDA) for the period January 2019 to March 2020 inclusiv (NHS Digital)
National Diabetes Inpatient Audit (NaDIA) – 2019
The National Diabetes Inpatient Audit (NaDIA) measures the quality of diabetes care provided to people with diabetes while they are admitted to hospital whatever the cause, and aims to support quality improvement. Data is collected and submitted by hospital staff in England (NHS Digital)
National Diabetes Inpatient Audit – Harms, 2019
NaDIA-Harms is a mandatory year-round collection of four harms that can occur to diabetic inpatients in Acute hospitals in England (NHS Digital)
National Diabetes Audit Non-Diabetic Hyperglycaemia, 2018- 2019, Diabetes Prevention Programme
The NHS Diabetes Prevention Programme (NHS DPP) is a joint commitment from NHS England, Public Health England and Diabetes UK to deliver, at scale, evidence based behavioural interventions that can prevent or delay the onset of Type 2 diabetes in adults who have been identified as having non-diabetic hyperglycaemia (NHS Digital)
National Diabetes Audit – Care Processes and Treatment Targets, 1st Quarter ,January to June 2020
This is the quarterly release of data from the National Diabetes Audit (NDA). It is the mid-year data release for the first extraction of NDA 2020-21 data. It shows progress to date covering the period 1 January to 30 June 2020 (NHS Digital)
National diabetes registries: do they make a difference?
National diabetes registries confer clear insights into diagnostics, complications, and treatment. The extent to which registries influenced national healthcare policy was less clear (Acta Diabetologica)
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
We show that the use of FSL was associated with significantly improved glycemic control and hypoglycemia awareness and a reduction in hospital admissions (Diabetes Care)
ABCD COVID-19 & Diabetes: UK national audit
This audit aims to explore the clinical features and presentation of people admitted with diabetes and COVID-19. Through capturing detailed real-world data on the clinical presentation, co-morbidities, therapies and outcomes we hope to gain better insight into the impact of COVID-19 on those living with diabetes (ABCD)
Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation
This analysis shows that additional cost of provision of hospital services due to their diabetes comorbidities is £3 billion above that for non-diabetes, and that within this, T1DM has three times as much cost impact as T2DM. We suggest that supporting patients in diabetes management may significantly reduce hospital activity (BMJ)
Diabetes care – examining whether patients with diabetes receive the recommended care and treatment
Here we use data from the National Diabetes Audit and National Paediatric Diabetes Audit to look at how the quality of care for diabetics has changed over time (Nuffield Trust)
National Paediatric Diabetes Audit – Annual report 2018-19
The National Paediatric Diabetes Audit assess the care received by children and young people with diabetes in all Paediatric Diabetes Units (PDUs) across England and Wales (HQIP)
National Diabetes Statistics Report
Estimates of Diabetes and Its Burden in the United States (CDC)
Diabetes Prevention Programme – Quarterly Report, January to September 2019
This is the quarterly release of non-diabetic hyperglycaemia data collected from GP practices alongside the National Diabetes Audit (NDA)
- 1
- 2
- 3
- …
- 8
- Next Page »
Glycosmedia is also available as an App: